A Study to Evaluate Mesenchymal Stem Cell Product StromaForte ' s Effect on Cardiovascular Events

Conditions: Cardiovascular Diseases Interventions: Biological: Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) Sponsors: Cellcolabs Clinical LTD. Recruiting

https://clinicaltrials.gov/study/NCT06087848

Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials